Interventional procedure overview of endoscopic duodenal mucosal resurfacing for insulin resistance in type 2 diabetes
Closed for comments This consultation ended on at Request commenting lead permission
Indications and current treatment
T2D is a chronic metabolic condition characterised by insulin resistance and insufficient pancreatic insulin production, resulting in hyperglycaemia. The condition is commonly associated with obesity, physical inactivity, raised blood pressure, periodontitis, disturbed blood lipid levels and a tendency to develop thrombosis. It is recognised to lead to an increased cardiovascular and stroke risk.
Dietary control is the mainstay of T2D treatment. Weight loss and being active are also recommended to help manage the condition. In addition to lifestyle modification, T2D is controlled using metformin, insulin or other medicines, with the aim of keeping a person's blood sugar levels within a healthy range. These treatments have varying efficacy and can sometimes cause side effects, including hypoglycaemia.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions